Skip to content

Correlation of Solitary Dilated Duct at Mammography With Ultrasonography and Anatomopathological Findings

Evaluation of Solitary Dilated Duct Visualized by Mammography in Correlation With Ultrasonography and Anatomopathological Findings.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03161392
Enrollment
135
Registered
2017-05-19
Start date
2016-03-16
Completion date
2019-07-29
Last updated
2019-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female, Mammary Duct Ectasia of Unspecified Breast, Mammographic Findings

Keywords

mammography, ductal ectasia, breast neoplasm/diagnostic imaging, mammary Glands, Human/pathology, female

Brief summary

Mammograms performed at the Diagnostic Imaging Department of the Instituto Brasileiro de Controle do Câncer (IBCC - Brazilian Cancer Control Institute) will be prospectively evaluated. Patients who present a solitary dilated duct visualized by mammography will be submitted to breast ultrasonography. In case of detection of lesion, a percutaneous biopsy will be performed.

Detailed description

Purpose: To determinate the incidence, pathological significance and risk factors associated with the presence of solitary dilated duct visualized at mammography exam. Methods: Mammograms performed at the Diagnostic Imaging Department of the Instituto Brasileiro de Controle do Câncer (IBCC - Brazilian Cancer Control Institute) will be prospectively evaluated. Patients who present a solitary dilated duct visualized by mammography will be included in the study. These patients will be recalled in order to be submitted to an ultrasonography directed to the mammographic finding. Patients who present lesions on ultrasonography will undergo method-guided percutaneous biopsy. Patients with ductal ectasia, without evident lesions, will be followed for 2 years to evaluate stability by means of mammography or ultrasonography every 6-month intervals.

Interventions

DIAGNOSTIC_TESTFollow-up

Group No ductal lesion will be submitted to follow-up with periodic breast ultrasonography/mammography every 6 months for 2 years.

DIAGNOSTIC_TESTUltrasound-guided percutaneous biopsy

Group Ductal lesion will be submitted to ultrasound-guided percutaneous biopsy and the specimen will be histologically analysed.

Sponsors

Instituto Brasileiro de Controle do Cancer
CollaboratorOTHER
Faculdade de Medicina do ABC
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Identification of a solitary dilated breast duct at mammography

Exclusion criteria

* Previous breast surgery at same side of detection of dilated duct

Design outcomes

Primary

MeasureTime frameDescription
Abnormal histological finding at breast biopsyAt guided-percutaneous biopsyDetection of any histological abnormality

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026